Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2026-04-18 @ 6:13 PM
Study NCT ID:
NCT01090466
Status:
COMPLETED
Last Update Posted:
2018-02-06
First Post:
2010-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
Sponsor:
Cardiff University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000667766
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None